ロード中...
mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1
Rapamycins are immunosuppressant and anti-cancer drugs that inhibit the kinase mTOR. Clinically, they often cause bone pain, bone necrosis, and high bone turnover, yet the mechanisms are unclear. Here we show that mTORC1 activity is high in osteoclast precursors but downregulated upon RANKL treatmen...
保存先:
| 出版年: | Commun Biol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6123628/ https://ncbi.nlm.nih.gov/pubmed/30271915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-018-0028-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|